Ifeoma N Asimadu1, Suhanyah Okeke2, Godwin C Onyebueke3. 1. Department of Ophthalmology, Enugu State University of Science and Technology, Enugu, Nigeria. ifeomaikojo@gmail.com. 2. Department of Ophthalmology, Enugu State University of Science and Technology, Enugu, Nigeria. 3. Department of Medicine, Enugu State University of Science and Technology, Enugu, Nigeria.
Abstract
PURPOSE: To evaluate the significance of sociodemographic and clinical variables on the quality of life of low-vision patients in a tertiary hospital in Enugu, Nigeria, and also determine the causative ocular pathologies and their vision-related quality of life. METHODS: A cross-sectional study of adults 18 years and above with low vision/blindness. They were consecutively enrolled and clinically evaluated. The WHO-NEI-VFQ-25 questionnaire for quality of life was administered. Descriptive statistics were used to summarize variables. Kruskal-Wallis test, analysis of variance, and post hoc tests were done where appropriate. RESULTS: Of the 400 participants, 81% were above 40 years. Mean age was 57.27 ± 16.34 years. Males (52.0%) and females (48.0%). 225 (56.25%) had Moderately Severe Visual Impairment. Low vision/blindness negatively affected the different domains of quality of life significantly, except ocular pain and dependency. Glaucoma and Cataract were the major disease conditions that affected most of the domains significantly. These conditions when poorly managed, due to poor and limited health resources, progress to low vision/blindness. Of all the socio-demographic factors and clinical variables studied, only age and severity of low vision were significant predictors of quality of life. CONCLUSION: There is the need for prompt and proper treatment of low-vision patients and advocacy for the establishment of adequate and functional rehabilitation services. Quality of life which measures the overall impact of a disease on an individual was low in people with low vision and blindness. Low-vision services, which include rehabilitation, will provide comprehensive eye-care services and thus improve their quality of life.
PURPOSE: To evaluate the significance of sociodemographic and clinical variables on the quality of life of low-vision patients in a tertiary hospital in Enugu, Nigeria, and also determine the causative ocular pathologies and their vision-related quality of life. METHODS: A cross-sectional study of adults 18 years and above with low vision/blindness. They were consecutively enrolled and clinically evaluated. The WHO-NEI-VFQ-25 questionnaire for quality of life was administered. Descriptive statistics were used to summarize variables. Kruskal-Wallis test, analysis of variance, and post hoc tests were done where appropriate. RESULTS: Of the 400 participants, 81% were above 40 years. Mean age was 57.27 ± 16.34 years. Males (52.0%) and females (48.0%). 225 (56.25%) had Moderately Severe Visual Impairment. Low vision/blindness negatively affected the different domains of quality of life significantly, except ocular pain and dependency. Glaucoma and Cataract were the major disease conditions that affected most of the domains significantly. These conditions when poorly managed, due to poor and limited health resources, progress to low vision/blindness. Of all the socio-demographic factors and clinical variables studied, only age and severity of low vision were significant predictors of quality of life. CONCLUSION: There is the need for prompt and proper treatment of low-vision patients and advocacy for the establishment of adequate and functional rehabilitation services. Quality of life which measures the overall impact of a disease on an individual was low in people with low vision and blindness. Low-vision services, which include rehabilitation, will provide comprehensive eye-care services and thus improve their quality of life.
Authors: Kovin Naidoo; John H Kempen; Stephen Gichuhi; Tasanee Braithwaite; Robert J Casson; Maria Vittoria Cicinelli; Aditi Das; Seth R Flaxman; Jost B Jonas; Jill Elizabeth Keeffe; Janet Leasher; Hans Limburg; Konrad Pesudovs; Serge Resnikoff; Alexander J Silvester; Nina Tahhan; Hugh R Taylor; Tien Y Wong; Rupert R A Bourne Journal: Br J Ophthalmol Date: 2020-03-30 Impact factor: 4.638
Authors: Fatima Kyari; Murthy V S Gudlavalleti; Selvaraj Sivsubramaniam; Clare E Gilbert; Mohammed M Abdull; Gabriel Entekume; Allen Foster Journal: Invest Ophthalmol Vis Sci Date: 2008-12-30 Impact factor: 4.799
Authors: John M Nesemann; Ram P Kandel; Raghunandan Byanju; Bimal Poudyal; Gopal Bhandari; Sadhan Bhandari; Kieran S O'Brien; Valerie M Stevens; Jason S Melo; Jeremy D Keenan Journal: Eye (Lond) Date: 2021-03-17 Impact factor: 3.775
Authors: Rupert R A Bourne; Seth R Flaxman; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor Journal: Lancet Glob Health Date: 2017-08-02 Impact factor: 26.763
Authors: Gertrudis I J M Kempen; Jolanda C M van Haastregt; Kevin J McKee; Kim Delbaere; G A Rixt Zijlstra Journal: BMC Public Health Date: 2009-06-02 Impact factor: 3.295